DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1CEDAX
02 1CEPHALEXIN
03 1DYAZIDE
04 1ERGOCALCIFEROL
05 1EXTENDED PHENYTOIN SODIUM
06 1HYDROXYUREA
07 4LOXAPINE SUCCINATE
08 1NORTRIPTYLINE HYDROCHLORIDE
09 3OXAZEPAM
10 1SURMONTIL
11 2TEMAZEPAM
12 1TETRACYCLINE HYDROCHLORIDE
01 116042
02 116792
03 140684
04 150685
05 161837
06 162702
07 171427
08 171428
09 171756
10 171813
11 171814
12 172062
13 172204
14 172205
15 172206
16 173556
17 175143
18 191004
01 18No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : NORTRIPTYLINE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 73556
Country : US
Patented : No
Drug : LOXAPINE SUCCINATE
Dosage Form : CAPSULE; ORAL
Application Number : 72206
Country : US
Patented : No
Drug : LOXAPINE SUCCINATE
Dosage Form : CAPSULE; ORAL
Application Number : 72205
Country : US
Patented : No
Drug : LOXAPINE SUCCINATE
Dosage Form : CAPSULE; ORAL
Application Number : 72204
Country : US
Patented : No
Drug : LOXAPINE SUCCINATE
Dosage Form : CAPSULE; ORAL
Application Number : 72062
Country : US
Patented : No
Drug : TETRACYCLINE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 61837
Country : US
Patented : No
Drug : HYDROXYUREA
Dosage Form : CAPSULE; ORAL
Application Number : 75143
Country : US
Patented : No
Drug : TEMAZEPAM
Dosage Form : CAPSULE; ORAL
Application Number : 71427
Country : US
Patented : No
Drug : SURMONTIL
Dosage Form : CAPSULE; ORAL
Application Number : 16792
Country : US
Patented : No
Drug : CEDAX
Dosage Form : CAPSULE; ORAL
Application Number : 50685
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
